Table 4. Markers associated with early re-exacerbation at the end of PE treatment.

	Early PE (n = 6)	Late PE (n = 6)	p- value
Days until next PE mean (min – max)	17.3 (1–29)	142.5 (56–365)	N/A
FEV1% predicted (%)	38.5 (7.2)	50.0 (8.5)	0.328
FVC% predicted (%)	56.5 (9.9)	64.0 (10.0)	0.606
Matouk Total score	46.5 (6.2)	56.8 (3.7)	0.180
QOL Total score	752.0 (86.7)	765.5 (62.8)	0.902
CRP (mg/L)	42.5 (26.1)	5.2 (2.7)	0.045*
IL-6 (pg/ml)	4.9 (1.6)	2.6 (0.6)	0.199
IL-8 (pg/ml)	3.9 (0.4)	2.7 (0.3)	0.034*
IL-10 (pg/ml)	24.4 (2.5)	77.0 (37.8)	0.195

Data presented as mean (SEM) unless specified. * indicates significant difference between the groups using Student's t-test or Mann-Whitney test if values were not normally distributed.